Ronald Blue Trust, Inc. Bridge Bio Pharma, Inc. Transaction History
Ronald Blue Trust, Inc.
- $7.7 Billion
- Q4 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 359 shares of BBIO stock, worth $11,333. This represents 0.0% of its overall portfolio holdings.
Number of Shares
359
Previous 757
52.58%
Holding current value
$11,333
Previous $20,000
55.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$797 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$793 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$476 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$393 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$195 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.68B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...